Cargando…
Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway
PURPOSE: This study aims to explore the function of metformin in hypopharyngeal squamous cell carcinoma (HSCC) and the underlying mechanism. METHODS: Cell viability, colony formation, cell apoptosis, and cell cycle were investigated using cell counting kit-8 assay, colony formation, and flow cytomet...
Autores principales: | Chen, Xiaoqiang, Li, Chen, Chen, Wei, Lin, Shuchun, Yi, Xuehan, Lin, Qin, Xu, Hao, Wang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295003/ https://www.ncbi.nlm.nih.gov/pubmed/34335751 http://dx.doi.org/10.1155/2021/2265475 |
Ejemplares similares
-
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)
por: Kikkawa, N, et al.
Publicado: (2010) -
The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients
por: Tsou, Yung-An, et al.
Publicado: (2019) -
Expression and predictive value of miR-489 and miR-21 in melanoma metastasis
por: Mo, Hao, et al.
Publicado: (2019) -
Hsa_circ_0003220 Drives Chemoresistance of Human NSCLC Cells by Modulating miR-489-3p/IGF1
por: Xia, Shaofeng, et al.
Publicado: (2023) -
Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis
por: Li, Fanfan
Publicado: (2020)